関連する実験動画
Updated: Jan 24, 2026

06:51
Physical Activity Measurement in Children Accepting Table Tennis Training
Published on: July 27, 2022
2.3K
ランダム化,アクティブ・コントロール,オープンフェーズ3試験
Erik A Imel1, Francis H Glorieux2, Michael P Whyte3
1Department of Medicine and Department of Pediatrics, Indiana University School of Medicine, Indianapolis, IN, USA.
Lancet (London, England)
|May 21, 2019
まとめ
伝統的な治療法と比較して,X関連低リン酸性血症の小児では,ブルースマブがラキットの重症度および成長を有意に改善しました. この研究は,この稀な遺伝疾患に対するより効果的な治療法として,ブルースマブを強調しています.
科学分野:
- 小児内分泌学
- 珍しい 遺伝 的 な 疾患
- 骨格発育不全
背景:
- X関連低血症 (XLH) は,子供のFGF23値上昇,低血症,および成長障害によって特徴づけられる珍しい遺伝疾患である.
- 従来の治療は口服用リン酸と活性ビタミンDを用いますが,重症の場合の有効性は限られています.
研究 の 目的:
- 抗FGF23抗体のブルースマブの有効性と安全性を,小児X関連低リン酸性血症の治療における従来の治療法と比較する.
- XLHの小児におけるライキットの重症度,成長,生化学的パラメータに対するブルースマブの影響を評価する.
主な方法:
- ランダム化され,アクティブ・コントロールされ,オープンなフェーズ3試験では,XLHを投与した61人の子供 (年齢1~12歳) が登録されました.
- 患者はランダムに分けられ,64週間の間にわたって皮下ブルースマブまたは従来の治療を受けた.
- 主なエンドポイントは,40週間のラキットの重度の変化であり,RGICスコアで評価された.
主要な成果:
- ブルースマブ群は,従来の治療群と比較して40週目にRGICスコアで有意に改善した (1. 9対0. 8,p< 0. 0001).
- ブルースマブで治療された子供たちは,痛風の重症度,成長,および生化学の有意な改善を経験しました.
- ブルースマブ群では有害事象の頻度が高く (59% 対 22%),重篤な有害事象は同様で,治療とは無関係であった.
結論:
- 伝統的な治療法と比較して,X関連低リン酸性血症の小児におけるラキットの重症度および成長の改善において,ブルースマブは優れた有効性を示しています.
- ブルースマブは,小児XLHの管理のための有望な治療法であり,重要な臨床的利益をもたらします.
関連する概念動画
Phase-lead and Phase-lag Controllers
540
Understanding the working function of different types of controllers can be illustrated with practical analogies, such as adjusting a stereo's volume equalizer. Cranking up the bass involves a phase-lead controller, which functions as a high-pass filter, while increasing the treble uses a phase-lag controller, which acts as a low-pass filter. PD controllers, similar to high-pass filters, enhance the system's response to high-frequency components. PI controllers, akin to low-pass...
540
Drug Administration and Therapy Phases: Overview
1.3K
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
1.3K
Covalently Linked Protein Regulators
8.9K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
8.9K
ortho–para-Directing Activators: –CH3, –OH, –⁠NH2, –OCH3
7.3K
All ortho–para directors, excluding halogens, are activating groups. These groups donate electrons to the ring, making the ring carbons electron-rich. Consequently, the reactivity of the aromatic ring towards electrophilic substitution increases. For instance, the nitration of anisole is about 10,000 times faster than the nitration of benzene. The electron-donating effect of the methoxy group in anisole activates the ortho and para positions on the ring and stabilizes the corresponding...
7.3K
Time and frequency -Domain Interpretation of Phase-lead Control
437
Phase-lead controllers are commonly used in various control systems to enhance response speed and stability. Adjusting the brightness on a television screen offers a practical example of phase-lead control. When contrast is enhanced, a phase-lead controller is employed. Mathematically, phase-lead control is identified when the first parameter is smaller than the second.
The design of phase-lead control involves the strategic placement of poles and zeros to balance steady-state error and system...
The design of phase-lead control involves the strategic placement of poles and zeros to balance steady-state error and system...
437
Time and frequency -Domain Interpretation of Phase-lag Control
402
Phase-lag controllers are widely used in control systems to improve stability and reduce steady-state errors. A dimmer switch controlling the brightness of a light bulb serves as a practical example of phase-lag control, gradually adjusting the bulb's brightness. Mathematically, phase-lag control or low-pass filtering is represented when the factor 'a' is less than 1.
Phase-lag controllers do not place a pole at zero, but instead influence the steady-state error by amplifying any...
Phase-lag controllers do not place a pole at zero, but instead influence the steady-state error by amplifying any...
402

